Decentralized Trials STREAM

  1. Transforming Cardiac Monitoring In Biopharma With 6-Lead And 12-Lead Devices 7/30/2025

    Learn how you can monitor a large number of cardiac conditions in real-time and support clinical trials across phases and TAs.

  2. The Past, Present, And Future Of Mobile Visits In DCTs 9/5/2024

    From pandemic-driven adoption to a new era of patient-centric research, experts share insights and strategies for the future of decentralized clinical trials (DCTs).

  3. The Transformation Of Clinical Data Capture And Management 10/25/2021

    Learn how the rapidly evolving clinical data capture landscape influences the challenges clinical data management teams face, and the emerging technology, processes, and skillsets that can help the industry adapt.

  4. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  5. The New Vaccine Race: Why A Decentralized Approach Wins 3/29/2022

    What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.

  6. The Evolution Of Data Capture And Its Impact On Management 12/7/2022

    As the volume and variety of clinical trial data have exploded - including electronic health records (EHR), sensors, and ePRO data - processes to manage and monitor that data have not kept pace. These processes are still grounded in a retroactive data review and reconciliation with a primary focus on eCRF data.

  7. Roundtable Patient Insights: Patients' Views On DCTs 11/29/2022

    In this brief roundtable session, patient advocates are interviewed to voice their views on decentralized clinical trials.

  8. IRT And Direct-To-Patient Trials 1/12/2022

    Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.